Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
Pethidine Hydrochloride 50mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Clear, colourless, sterile solution intended for parenteral administration to human beings. |
Each 1ml of solution contains 50mg of Pethidine Hydrochloride B.P..
| Active Ingredient | Description | |
|---|---|---|
| Pethidine |
Pethidine is a synthetic opioid analgesic similar with similar actions to morphine. Like other opioids, pethidine binds to opioid receptors and exerts its principal pharmacological actions on the central nervous system where its analgesic and sedative effects are of particular therapeutic value. Pethidine also causes the release of histamine from mast cells resulting in a number of allergic-type reactions. |
| List of Excipients |
|---|
|
Sodium hydroxide B.P. |
1ml and 2ml clear glass ampoules, glass type 1 Ph. Eur. packed in cardboard cartons to contain 10 × 1ml or 10 × 2ml ampoules.
Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0596
Date of first authorisation: 10/05/82
Date of renewal: 13/03/97
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
